Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Max Conway

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Optometry and Vision Science : Official Publication of the American Academy of Optometry|April 23, 2025
Survey of Australian primary eyecare management of choroidal nevus patientsR Max Conway, Thi Minh Thi Trang, Erin J Tang, et al.
Biochimie|January 30, 2022
The unfolded protein response and the biology of uveal melanomaStanley Zhang, Ke Wang, Xue Zhu, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 5, 2022
The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanomaWenying Shu, Xue Zhu, Ke Wang, et al.
The Journal of Pharmacy and Pharmacology|May 9, 2022
The application of natural compounds in uveal melanoma drug discoveryYihe Niu, Ke Wang, Xue Zhu, et al.
The FEBS Journal|April 10, 2021
Development of new therapeutic options for the treatment of uveal melanomaJanney Z Wang, Vivian Lin, Elsa Toumi, et al.
Pigment Cell & Melanoma Research|March 22, 2021
The role of melanocytes in the human choroidal microenvironment and inflammation: Insights from the transcriptomeAdrian V Cioanca, Chieh-Lin Stanley Wu, Riccardo Natoli, et al.
Journal of Cancer|November 29, 2023
Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cellsWenying Shu, Janney Z Wang, Xue Zhu, et al.
Cancers|January 8, 2025
Microdissection of Distinct Morphological Regions Within Uveal Melanomas Identifies Novel Drug TargetsElsa Toumi, Luke B Hesson, Vivian Lin, et al.
Progress in Retinal and Eye Research|May 22, 2023
The multifunctional human ocular melanocortin systemChieh-Lin Stanley Wu, Adrian V Cioanca, Maria C Gelmi, et al.
European Journal of Pharmacology|March 16, 2026
UC2288 decreases the viability and metastatic activity of human Uveal Melanoma cells via activating the AMPK/eIF2/ATF4 ER stress axisJanney Z Wang, Yihe Niu, Xue Zhu, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Optometry and Vision Science : Official Publication of the American Academy of Optometry|April 23, 2025
Survey of Australian primary eyecare management of choroidal nevus patientsR Max Conway, Thi Minh Thi Trang, Erin J Tang, et al.
Biochimie|January 30, 2022
The unfolded protein response and the biology of uveal melanomaStanley Zhang, Ke Wang, Xue Zhu, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 5, 2022
The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanomaWenying Shu, Xue Zhu, Ke Wang, et al.
The Journal of Pharmacy and Pharmacology|May 9, 2022
The application of natural compounds in uveal melanoma drug discoveryYihe Niu, Ke Wang, Xue Zhu, et al.
The FEBS Journal|April 10, 2021
Development of new therapeutic options for the treatment of uveal melanomaJanney Z Wang, Vivian Lin, Elsa Toumi, et al.
Pigment Cell & Melanoma Research|March 22, 2021
The role of melanocytes in the human choroidal microenvironment and inflammation: Insights from the transcriptomeAdrian V Cioanca, Chieh-Lin Stanley Wu, Riccardo Natoli, et al.
Journal of Cancer|November 29, 2023
Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cellsWenying Shu, Janney Z Wang, Xue Zhu, et al.
Cancers|January 8, 2025
Microdissection of Distinct Morphological Regions Within Uveal Melanomas Identifies Novel Drug TargetsElsa Toumi, Luke B Hesson, Vivian Lin, et al.
Progress in Retinal and Eye Research|May 22, 2023
The multifunctional human ocular melanocortin systemChieh-Lin Stanley Wu, Adrian V Cioanca, Maria C Gelmi, et al.
European Journal of Pharmacology|March 16, 2026
UC2288 decreases the viability and metastatic activity of human Uveal Melanoma cells via activating the AMPK/eIF2/ATF4 ER stress axisJanney Z Wang, Yihe Niu, Xue Zhu, et al.
Pageof 4